Navigation Links
Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research
Date:7/7/2009

WASHINGTON, July 7 /PRNewswire-USNewswire/ -- Cardinal Justin Rigali, Chairman of the U.S. Catholic Bishops' Committee on Pro-Life Activities, reacted today to final guidelines for human embryonic stem cell research issued yesterday by the National Institutes of Health (NIH). The text of his statement follows:

"In April I criticized the NIH's draft guidelines for destructive embryonic stem cell research, saying that under these guidelines 'federal tax dollars will be used to encourage destruction of living embryonic human beings for stem cell research - including human beings who otherwise would have survived and been born.'

"The final guidelines issued yesterday are even broader. Parents who are asked to consider having their embryonic children destroyed for research will not even have to be informed about all their other options - only about the options that happen to be available at their particular fertility clinic. Moreover, under the final guidelines, stem cell lines that existed previously or that are produced in foreign countries may be made eligible for federally funded research even if they were obtained in ways that violate one or more of the NIH's own informed consent requirements.

"The comments of tens of thousands of Americans opposing the destruction of innocent human life for stem cell research were simply ignored in this process. Even comments filed by the Catholic bishops' conference and others against specific abuses in the draft guidelines were not addressed. For example, federally funded researchers will be allowed to insert human embryonic stem cells into the embryos of animal species other than primates; federal grants will be available even to researchers who themselves destroyed human embryos to obtain the stem cells for their research. Existing federal law against funding research in which human embryos are harmed or destroyed is not given due respect here.

"This debate now shifts to Congress, where some members have said even this policy does not go far enough in treating some human beings as objects to be created, manipulated and destroyed for others' use. I hope Americans concerned about this issue will write to their elected representatives, urging them not to codify or further expand this unethical policy."

For more information about the USCCB's "Oppose Destructive Stem Cell Research" campaign, visit www.usccb.org/stemcellcampaign. Cardinal Rigali's April 21 statement on the draft guidelines is at www.usccb.org/comm/archives/2009/09-087.shtml. The USCCB's official comment letter of May 22 is at www.usccb.org/prolife/NIHcomments.pdf.


'/>"/>
SOURCE U.S. Conference of Catholic Bishops Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
2. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
3. Cardinal Health To Announce First-Quarter Results on November 5
4. Cardinal Health Announces Sector Management Change
5. Cardinal Health Reports First Quarter Results
6. Cardinal Health, Sentry Data Systems Introduce New Technology to Help Health Care Providers More Cost-Efficiently Care for Underserved
7. Cardinal Health Receives DEA Order to Temporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility
8. Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHIS 5 Million Lives Campaign
9. Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility
10. Cardinal Health to Announce Second-Quarter Results on January 29
11. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... 2016 Top 20 Marketing Campaign Winner in the Folio: Marketing Awards competition. Live ... recognize the year’s best in pioneering, inventive, and ultimately successful projects undertaken by ...
(Date:12/7/2016)... City, CA (PRWEB) , ... December 07, 2016 , ... ... during the holidays and winter seasons. One major study analyzing heart attacks among ... compared to August of a given year. We would all agree of course–no time ...
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX ... media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes ... use drop zones. Editors can select from a variety of flip book animations. In ...
(Date:12/7/2016)... CINCINNATI, Ohio (PRWEB) , ... December 07, 2016 ... ... winner in the 2016 BOC Business Brilliance Awards under the Best New Product ... inception and results achieved through user experience. , BOC Global Events & Training ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... its newest portable bioelectronic medicine device WellnessPro Plus for consumers and healthcare ... enhances the WellnessPro platform by expanding the treatment modalities available in a ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016  Nearly 30 million people ... from the epidemic of diabetes. 1 However, nearly ... elevated glucose levels (hyperglycemia) and significant glucose variability. 2 ... complications, including cardiovascular events. If left untreated, hyperglycemia can ... eye disease or blindness. 3 As ...
(Date:12/6/2016)... With opioids commonly used for pain management for workplace ... that has led to nationwide fatalities. The synthetic opioid ... than heroin or morphine, resulting in likelihood of addiction, abuse or ... , , ... operations, Behavioral Health for HMC HealthWorks, explained the opioid drug is ...
(Date:12/6/2016)... , Dec. 6, 2016  Blueprint Medicines Corporation ... and developing targeted kinase medicines for patients with genomically ... underwritten public offering of $125,000,000 million in shares of ... grant the underwriters a 30-day option to purchase up ... its common stock in connection with the public offering. ...
Breaking Medicine Technology: